ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2119

Off Work Days Decreased RATE in Muskuloeskeletal Disease Patients: Usefulness of the EARLY Intervention Program

Francisco Miguel Ortiz Sanjuan, Isabel Martinez-Cordellat, Jose Ivorra, Jose Luis Valero, Inmaculada Chalmeta, Elena Grau, Carlos Feced, Rosa Negueroles, Luis Gonzalez-Puig, Cristobal Nuñez-Cornejo Piquer, Cristina Alcañiz, Eztizen Labrador and Jose Andres Roman Ivorra, Department of Rheumatology, Hospital Universitario y Politécnico La Fe., Valencia, Spain

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Intervention and Musculoskeletal

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Health Services Research

Session Type: Abstract Submissions (ACR)

Background/Purpose

In March 2012, a new project was started at HUP La Fe following the pilot project carried out at San Carlos Clinical Hospital in Madrid, where patients who were off work for musculoskeletal causes were referred to us from Primary Care. The aim of the study is to analyze the variation in days off work in those individuals included in this program with respect to the normal average of days off.

Methods

Cohort, observational, cross-sectional study from April 2012 to December 2013, which included patients from the HUP La Fe area, referred for the first time to the Rheumatology Early Intervention consultation program because of temporary disability due to musculoskeletal problems. These patients are referred to a medical appointment with a maximum waiting time of one week and were provided medical treatment, ultrasound, joint injections and directed exercises if needed. The patient is reviewed continuously until discharge. We excluded patients whose disabilities were due to trauma or surgery or if their situation could cause permanent disability.

Results

We included a total of 250 patients with a mean age of 48 years and 53% were women. The most frequently reported diseases were: back pain (33%), neck pain (16%), shoulder pain syndrome (13%) and other tendinopathies (10%). 100% of patients received medical treatment, 39% underwent articular ultrasound, 35% of them underwent injections and 82% were trained to perform physical therapy exercises at home. The pathology that had a higher average number of days from the first visit to the medical discharge was lumbar/sciatic pain (38 days), neck pain (30 days), and painful shoulder syndrome (34 days). Comparing our data with the control population in the San Carlos Hospital study, there was a decrease of the days off, being in the control group lumbociatalgia (57.6 days), neck (37.4 days) and neck pain (37.4 days).

Conclusion

Results obtained in our study show that early intervention by rheumatologists in patients with temporary disability of musculoskeletal origin decreases the number of days off work compared to patients who receive routine treatment and they can be incorporated in work early. Consequently, it saves all costs resulting from such temporary disability.


Disclosure:

F. M. Ortiz Sanjuan,
None;

I. Martinez-Cordellat,
None;

J. Ivorra,
None;

J. L. Valero,
None;

I. Chalmeta,
None;

E. Grau,
None;

C. Feced,
None;

R. Negueroles,
None;

L. Gonzalez-Puig,
None;

C. Nuñez-Cornejo Piquer,
None;

C. Alcañiz,
None;

E. Labrador,
None;

J. A. Roman Ivorra,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/off-work-days-decreased-rate-in-muskuloeskeletal-disease-patients-usefulness-of-the-early-intervention-program/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology